Department of Veterinary Public Health, National School of Public Health, Athens, Greece.
Vet J. 2010 Nov;186(2):262-3. doi: 10.1016/j.tvjl.2009.08.001. Epub 2009 Sep 3.
Canine leishmaniosis (CL) is a common systemic parasitic disease that is endemic in many Mediterranean countries including Greece. The immune reaction to the parasite is critical to the outcome of the infection and the response to treatment. Some studies have shown a reduction of circulating CD4+ T cells and of the CD4+/CD8+ ratio in dogs with CL and these changes normalised following treatment with meglumine antimoniate or amphotericin B. Allopurinol is used as a monotherapy for the chronic treatment of CL. The aim of the present study was to determine the circulating CD4+ and CD8+ T lymphocyte numbers and the CD4+/CD8+ ratio in 19 dogs diagnosed with CL before and after prolonged allopurinol monotherapy (18 months). A significant decrease in circulating CD4+ T cells was observed in dogs with CL before treatment. Prolonged allopurinol monotherapy improved the number of circulating CD4+ T cells, but did not restore their number to within the normal range.
犬利什曼病(CL)是一种常见的系统性寄生虫病,在地中海国家包括希腊流行。对寄生虫的免疫反应对感染的结果和对治疗的反应至关重要。一些研究表明,患有 CL 的狗的循环 CD4+ T 细胞和 CD4+/CD8+ 比值减少,并且在用氨苯砜或两性霉素 B 治疗后这些变化恢复正常。别嘌醇被用作 CL 的慢性治疗的单一疗法。本研究的目的是确定 19 只诊断患有 CL 的狗在长期别嘌醇单一疗法(18 个月)前后循环 CD4+和 CD8+T 淋巴细胞数量和 CD4+/CD8+比值。在治疗前,患有 CL 的狗的循环 CD4+T 细胞数量显著减少。长期别嘌醇单一疗法可改善循环 CD4+T 细胞数量,但未能使其数量恢复正常范围。